AirBoss Defense Group and Maddox Defense partner with Access Bio to deliver US-made COVID test kits to defense logistics agency

NEWMARKET — AirBoss of America announced that the Defense Logistics Agency (DLA) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to US$410 million to Access Bio, an industry leader in medical testing and diagnostics, supported by a U.S. coalition including AirBoss Defense Group (ADG), Maddox Defense, and a network of US test kit component suppliers.

The contract for the delivery of Made in America COVID test kits supports the US Government’s response to the COVID pandemic. The award demonstrates the US Government’s shift toward an American-made and sourced policy that is intended to ensure domestic industrial base capability and capacity in areas critical to the US response to any national emergency.

Access Bio has already received, and commenced deliveries under, the first order of approximately one half of this IDIQ contract, valued at US$205 million. ADG expects to generate US$19 million in revenue during the next six months as this order is completed, and up to an aggregate of US$38 million over the lifetime of the contract.

“We are very proud of ADG’s continued support of US government preparedness efforts and ADG’s commitment to being a key partner in further developing US made and sourced manufacturing capabilities either as a prime contractor or through the establishment of special purpose coalitions,” said Gren Schoch, CEO of AirBoss. “ADG has been focused on finding best-in-class partners and capabilities to further its leadership in the survivability and healthcare product sectors. Diagnostics and testing supplies have been an essential part of the US Government’s COVID pandemic response, and this award validates the ongoing efforts of ADG to build a domestic supply chain for both personal protective equipment and diagnostic equipment.”